Heska Corp (HSKA): Sharon L. Riley , director of Heska Corp sold 5,000 shares on May 10, 2016. The Insider selling transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were sold at $36.87 per share for a total value of $184,365.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 10, 2016, Michael J Mcginley (Presi, Biologic. & Pharm.) sold 5,998 shares at $36.50 per share price.On May 9, 2016, Kevin S. Wilson (CEO and President) sold 11,000 shares at $35.63 per share price.Also, On May 9, 2016, Sharon L. Riley (director) sold 15,000 shares at $35.66 per share price.On May 5, 2016, Jason A Napolitano (COO, CFO, EVP and Secretary) sold 5,000 shares at $35.75 per share price.
Shares of Heska Corp (HSKA) ended Friday, May 6, 2016 session in red amid volatile trading. The shares closed down -0.19 points or -0.54% at $35.11 with 50,657 shares getting traded. Post opening the session at $35, the shares hit an intraday low of $34.5 and an intraday high of $35.48 and the price vacillated in this range throughout the day. The company has a market cap of $232 M and the number of outstanding shares has been calculated to be 66,20,292 shares. The 52-week high of Heska Corp is $40.29 and the 52-week low is $23.22.
Company has been under the radar of several Street Analysts.Heska Corp is Initiated by CL King to Buy. The Rating was issued on Apr 1, 2016.
Heska Corporation develops manufactures markets sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. The Company operates in two segments: Core Companion Animal Health and Other Vaccines Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes primarily for canine and feline use blood testing instruments and supplies digital imaging products software and services and single use products and services such as heartworm diagnostic tests heartworm preventive products allergy immunotherapy products and allergy testing. The Other Vaccines Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production primarily for cattle but also for other animals including small mammals.